Collegium Pharmaceutical Inc’s filing revealed that its EVP and Chief Medical Officer Smith Thomas B unloaded Company’s shares for reported $36580.0 on Feb 29 ’24. In the deal valued at $36.76 per share,995 shares were sold. As a result of this transaction, Smith Thomas B now holds 63,409 shares worth roughly $2.24 million.
Then, Dreyer Scott sold 10,000 shares, generating $364,270 in total proceeds. Upon selling the shares at $36.43, the EVP & Chief Commercial Officer now owns 138,918 shares.
Before that, Dreyer Scott sold 23,560 shares. Collegium Pharmaceutical Inc shares valued at $760,519 were divested by the EVP & Chief Commercial Officer at a price of $32.28 per share. As a result of the transaction, Dreyer Scott now holds 111,322 shares, worth roughly $3.94 million.
Jefferies downgraded its Collegium Pharmaceutical Inc [COLL] rating to a Hold from a a Buy in a research note published on January 04, 2024; the price target was increased to $37 from $30. A number of analysts have revised their coverage, including Needham’s analysts, who remained covering the stock and in late August has reiterated a ‘”a Buy”‘ rating for it. H.C. Wainwright revised its rating on August 08, 2022. It rated COLL as “a Neutral” which previously was an “a Buy”.
Price Performance Review of COLL
On Tuesday, Collegium Pharmaceutical Inc [NASDAQ:COLL] saw its stock jump 0.74% to $35.40. Over the last five days, the stock has lost -8.74%. Collegium Pharmaceutical Inc shares have risen nearly 15.01% since the year began. Nevertheless, the stocks have risen 54.38% over the past one year. While a 52-week high of $40.95 was reached on 03/28/24, a 52-week low of $20.83 was recorded on 01/02/24. SMA at 50 days reached $36.67, while 200 days put it at $28.13. A total of 0.32 million shares were traded, compared to the trading of 0.38 million shares in the previous session.
Levels Of Support And Resistance For COLL Stock
The 24-hour chart illustrates a support level at 34.82, which if violated will result in even more drops to 34.25. On the upside, there is a resistance level at 35.89. A further resistance level may holdings at 36.39. The Relative Strength Index (RSI) on the 14-day chart is 37.23, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.77, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.39%. Stochastics %K at 5.11% indicates the stock is a buying.
